{
    "2019-01-31": [
        [
            {
                "time": "2018-03-15",
                "original_text": "This Pharma Stock Broke Out On Its Merck-Partnered Cancer Regimen",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Broke Out",
                        "Merck-Partnered",
                        "Cancer Regimen"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-06",
                "original_text": "Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q4 Earnings",
                        "Coming Up"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "FDA Expands Lilly's ALIMTA速 (pemetrexed) Label with Combination of KEYTRUDA速 (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer",
                "features": {
                    "keywords": [
                        "FDA",
                        "Expands",
                        "Lilly's ALIMTA速",
                        "KEYTRUDA速",
                        "Platinum Chemotherapy",
                        "First-Line Treatment",
                        "Metastatic Nonsquamous Non-Small Cell Lung Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}